This proposal explores the interaction of mitochondrial fusion dynamics and transmembrane potential (??m) as an underlying mechanism and translational target in diabetic cardiovascular damage. Type 2 diabetes mellitus is a rapidly-increasing public health concern, causing decreased cardiac efficiency which is the leading cause of mortality among Type 2 diabetics. A range of clinical and experimental data suggests that the cytokine-mediated inflammation that drives diabetic pathology directly damages mitochondria, the organellar network responsible for cellular bioenergetics. Crucially, however, it is unknown what level of mitochondrial damage can be sustained in highly-oxidative cardiac cells before pathology ensues. Our current SC3 support has provided novel mechanistic insights motivating the proposed aims: 1) to explore how the OMA1 stress-responsive protease is activated by loss of ??m, 2) the role of OPA1 levels in determining mitochondrial fusion homeostasis, and 3) the time-dependent nature of ??m-sensitive mitochondrial fusion dynamics. These experiments will leverage our published cell-based imaging and functional assays to further explore this gap in knowledge. To maintain bioenergetic homeostasis, mitochondria balance their organization between a united, reticular network (OPA1-mediated fusion) and a fragmented population of individual organelles (DRP1-mediated fission). The ??m across the mitochondrial inner membrane is required for mitochondrial fusion, linking organellar function and structural dynamics: we demonstrated previously that a sharply-defined threshold of 34% ??m is required for mitochondrial fusion. Strikingly, our current data indicates that a similar threshold exists in cardiac-derived cells, and that this threshold is mediated by OMA1, a stress- response protease that cleaves the mitochondrial OPA1 fusion protein in response to low ??m. Further, our data suggests that novel intramolecular domains are required for OMA1 to sense loss of ??m. Our project will mechanistically explore this threshold, as well as the impacts of cytokine-mediated damage on ??m and fusion dynamics and the time-integrated nature of mitochondrial stress-sensitive dynamics. This research has strong potential to inform a novel translational approach to protect cardiac mitochondria against cytokine-mediated damage.
Decreased cardiac efficiency is a major complication of Type 2 diabetes and is the leading cause of death among diabetics. While mitochondria, the organelles providing energy to the cell, have long been implicated in both diabetes and cardiovascular disease, emerging research indicates that the increased inflammation that causes Type 2 diabetes disrupts mitochondrial structure/function homeostasis in the diabetic heart. The proposed research will critically examine an emerging mechanism of mitochondrial structure/function homeostasis, uncovering the mechanistic impacts of cytokine-mediated inflammation, with major potential for discovering novel therapeutics to protect cardiac mitochondria from inflammatory damage. The proposed aims will directly support development of the P.I.?s research program and increase under-represented student access to research careers at a major Hispanic-serving institution.
| Garcia, Iraselia; Innis-Whitehouse, Wendy; Lopez, Alma et al. (2018) Oxidative insults disrupt OPA1-mediated mitochondrial dynamics in cultured mammalian cells. Redox Rep 23:160-167 |
| Gilkerson, Robert (2018) A Disturbance in the Force: Cellular Stress Sensing by the Mitochondrial Network. Antioxidants (Basel) 7: |
| Vazquez, Neftali; Sanchez, Lilia; Marks, Rebecca et al. (2018) A protocol for custom CRISPR Cas9 donor vector construction to truncate genes in mammalian cells using pcDNA3 backbone. BMC Mol Biol 19:3 |
| Garcia, Iraselia; Jones, Edith; Ramos, Manuel et al. (2017) The little big genome: the organization of mitochondrial DNA. Front Biosci (Landmark Ed) 22:710-721 |
| Jones, Edith; Gaytan, Norma; Garcia, Iraselia et al. (2017) A threshold of transmembrane potential is required for mitochondrial dynamic balance mediated by DRP1 and OMA1. Cell Mol Life Sci 74:1347-1363 |
| Gilkerson, Robert (2016) Commentary: Mitochondrial DNA damage and loss in diabetes. Diabetes Metab Res Rev 32:672-674 |
